Anna Maria Jegg

Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages

C. Gomez-Roca, Antoîne Italiano, Christophe Le Tourneau et al. · Annals of Oncology · 2019 · 202 citations · Full text

Life Sciences, Immunology, Oncology +16

Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor

Elizabeth Iorns, Toby M. Ward, Sonja Dean et al. · Breast Cancer Research and Treatment · 2012 · 54 citations

Life Sciences, Genetics, Oncology +10

An enhanced prognostic score for overall survival of patients with cancer derived from a large real-world cohort

Tim Becker, Janick Weberpals, Anna Maria Jegg et al. · Annals of Oncology · 2020 · 39 citations

Medicine, Biostatistics, Oncology +17